Report overview
Clostridium difficile is a disease caused by bacteria. Symptoms of the disease includes diarrhea, nausea, colon inflammation, and others. Causal organism for infectious diseases could be bacteria, viruses, parasites or fungi and can be spread, directly or indirectly, from one person to another. Molecular diagnostic is showing promise in the identification of microorganisms as well as evaluation of virulence factors and antibiotic resistance determinants. Molecular infectious diseases diagnosis is moving towards high-throughput, simple, array-type technologies that provide a wealth of data on types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. Molecular diagnostic helping infectious diseases to be more accurately and effectively treated.
This report contains market size and forecasts of Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment in global, including the following market information:
Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment companies in 2021 (%)
The global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pcr Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment include Cepheid, Beckton Dickinson, Gen Probe (Hologic), Qiagen, Roche, Bayer Healthcare, Dako, Abbott Laboratories and Danaher, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Segment Percentages, by Type, 2021 (%)
Pcr
In Situ Hybridization
Chips And Microarrays
Isothermal Nucleic Acid Amplification Technology (Inaat)
Mass Spectrometry
Sequencing
Transcription Mediated Amplification
Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Segment Percentages, by Application, 2021 (%)
Hospital
Research
Clinic
Others
Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment revenues share in global market, 2021 (%)
Key companies Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cepheid
Beckton Dickinson
Gen Probe (Hologic)
Qiagen
Roche
Bayer Healthcare
Dako
Abbott Laboratories
Danaher
Siemens
Sysmex
Grifols
Biom?rieux
